Differences and connections between tofacitinib and tofacitinib citrate

Tofacitinib is an oral small molecule JAK inhibitor that mainly inhibits the JAK1 and JAK3 signaling pathways, thereby blocking the activity of a variety of pro-inflammatory cytokines and achieving anti-inflammatory and immunoregulatory effects. The drug is widely used to treat immune diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, etc. It has good efficacy and is convenient for oral use.

Tofacitinib citrate is actually a salt form of tofacitinib, and its full name is "Tofacitinib Citrate". In pharmaceutical preparations, in order to improve the stability, solubility or oral absorption of the drug, active drug molecules are often formed into salts with certain acids or bases. Tofacitinib citrate is a salt formed by combining tofacitinib with citric acid. This form facilitates the drug to be made into tablets or capsules, making it easier to store and take.

It is worth noting that whether it is tofacitinib itself or tofacitinib citrate, after entering the body, the active ingredient that ultimately exerts its medicinal effect is "tofacitinib". In other words, there is no substantial difference in pharmacological effects between the two, but there are differences in dosage forms and formulations. When doctors prescribe it, it usually appears under the generic name "Tofacitinib", and its specific salt form may be indicated in the drug instructions or labels.

Therefore, tofacitinib and tofacitinib citrate are essentially the same drug, with the same mechanism of action and therapeutic indications. Patients do not need to worry too much about the difference between the two when using them. They only need to use the medicine according to the instructions of the doctor or pharmacist. If you have any questions about the ingredients and packaging names of the drugs, you can consult professionals to confirm whether they are the same drugs.

Reference materials:https://www.xeljanz.com/